Brian Lian

Insider Reports History

Location
New York, NY
Signature
/s/ Michael Morneau, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian Lian:

Company Role Class Num Shares Value Price $ Report Date Ownership
Viking Therapeutics, Inc. President & CEO, Director Common Stock, par value $0.00001 per share 2,499,291 $87,640,388 $35.07 05 Jan 2026 Direct
Viking Therapeutics, Inc. President & CEO, Director Stock Option (Right to Buy) 176,300 02 Jan 2026 Direct
SEELOS THERAPEUTICS, INC. Director Stock Option (right to buy) 1,666 04 Jan 2024 Direct

Insider Reports Filed by Brian Lian

Symbol Company Period Transactions Value $ Form Type Role Filing Time
VKTX Viking Therapeutics, Inc. 02 Jan 2026 7 -$7,692,121 4 President & CEO, Director 05 Jan 2026, 20:28
VKTX Viking Therapeutics, Inc. 27 Oct 2025 2 -$1,364,923 4 President & CEO, Director 28 Oct 2025, 19:48
VKTX Viking Therapeutics, Inc. 02 Jul 2025 2 -$747,633 4 President & CEO, Director 03 Jul 2025, 15:31
VKTX Viking Therapeutics, Inc. 03 Jan 2025 5 -$8,313,601 4 President & CEO, Director 06 Jan 2025, 20:16
VKTX Viking Therapeutics, Inc. 20 Sep 2024 5 -$14,017,723 4 President & CEO, Director 20 Sep 2024, 21:20
VKTX Viking Therapeutics, Inc. 21 Aug 2024 3 -$62,130 4 President & CEO, Director 22 Aug 2024, 19:23
VKTX Viking Therapeutics, Inc. 19 Aug 2024 5 -$6,549,508 4 President & CEO, Director 19 Aug 2024, 20:13
VKTX Viking Therapeutics, Inc. 29 Jul 2024 5 -$6,670,604 4 President & CEO, Director 31 Jul 2024, 16:05
VKTX Viking Therapeutics, Inc. 27 Mar 2024 2 -$12,830,026 4 President & CEO, Director 27 Mar 2024, 20:51
VKTX Viking Therapeutics, Inc. 01 Mar 2024 2 -$13,875,094 4 President & CEO, Director 04 Mar 2024, 19:54
VKTX Viking Therapeutics, Inc. 09 Feb 2024 1 -$1,345,500 4 President & CEO, Director 09 Feb 2024, 20:59
VKTX Viking Therapeutics, Inc. 08 Feb 2024 10 -$6,519,417 4 President & CEO, Director 08 Feb 2024, 19:40
VKTX Viking Therapeutics, Inc. 31 Jan 2024 4 -$1,996,200 4 President & CEO, Director 31 Jan 2024, 20:39
VKTX Viking Therapeutics, Inc. 30 Jan 2024 3 -$795,200 4 President & CEO, Director 30 Jan 2024, 21:05
/report/000110465924002384-lian-brian-2024-01-04 SEELOS THERAPEUTICS, INC. 04 Jan 2024 1 $0 4 Director 08 Jan 2024, 21:45
VKTX Viking Therapeutics, Inc. 03 Jan 2024 6 -$4,469,612 4 President & CEO, Director 04 Jan 2024, 21:37
VKTX Viking Therapeutics, Inc. 01 May 2023 1 -$1,010,250 4 President & CEO, Director 01 May 2023, 19:03
VKTX Viking Therapeutics, Inc. 19 Apr 2023 1 -$750,750 4 President & CEO, Director 21 Apr 2023, 19:29
VKTX Viking Therapeutics, Inc. 17 Apr 2023 3 -$2,901,016 4 President & CEO, Director 18 Apr 2023, 19:09
VKTX Viking Therapeutics, Inc. 13 Apr 2023 3 -$1,361,598 4 President & CEO, Director 13 Apr 2023, 17:14
VKTX Viking Therapeutics, Inc. 30 Mar 2023 12 -$6,752,419 4 President & CEO, Director 03 Apr 2023, 19:26
/report/000113626123000005-lian-brian-2023-01-05 SEELOS THERAPEUTICS, INC. 05 Jan 2023 1 $0 4 Director 05 Jan 2023, 18:18
VKTX Viking Therapeutics, Inc. 30 Dec 2022 6 -$1,444,073 4 President & CEO, Director 04 Jan 2023, 17:24
/report/000113626122000018-lian-brian-2022-01-05 SEELOS THERAPEUTICS, INC. 05 Jan 2022 1 $0 4 Director 06 Jan 2022, 19:02
VKTX Viking Therapeutics, Inc. 03 Jan 2022 4 -$299,353 4 President & CEO, Director 05 Jan 2022, 18:12
VKTX Viking Therapeutics, Inc. 28 Sep 2021 2 -$180,375 4 President & CEO, Director 30 Sep 2021, 17:48